Thrilled to announce that the Super Sam Foundation: Fighting Childhood Cancer has generously awarded Oncoheroes Biosciences with a grant
Oncoheroes Biosciences shared a post on LinkedIn:
“Incredible news! We’re thrilled to announce that the Super Sam Foundation: Fighting Childhood Cancer has generously awarded Oncoheroes Biosciences with a grant, marking the second occasion the foundation has supported our mission.
Their initial investment in June 2020 played a pivotal role in preparing our lead compound, Volasertib, for clinical trials. Now, with this funding, we’re excited to leverage the foundation’s support to launch the clinical trial of Volasertib, bringing us closer to advancing cancer therapeutics.
‘We’re once again thrilled to partner with the team to continue our support for Volasertib. This drug is full-circle for our Foundation, as we wish our Founding Hero, Sam, would have had this option during his fight 10 years ago. We deeply appreciate the incredible work Oncoheroes is doing in the childhood cancer community and excited to support their vital work,’ stated Cassie Santhuff, president and co-founder of the Super Sam Foundation.
A huge thank you to the Super Sam Foundation: Fighting Childhood Cancer for their unwavering dedication to our cause.”
Additional information.
Source: Oncoheroes Biosciences/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023